- Home
- CTNM vs PHH Comparison
CTNM vs PHH Comparison
Compare CTNM & PHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- PHH
- Stock Information
- Founded
- CTNM 2009
- PHH 2016
- Country
- CTNM United States
- PHH China
- Employees
- CTNM N/A
- PHH N/A
- Industry
- CTNM
- PHH Package Goods/Cosmetics
- Sector
- CTNM
- PHH Consumer Discretionary
- Exchange
- CTNM Nasdaq
- PHH Nasdaq
- Market Cap
- CTNM 199.3M
- PHH 160.1M
- IPO Year
- CTNM 2024
- PHH 2024
- Fundamental
- Price
- CTNM $7.59
- PHH $5.44
- Analyst Decision
- CTNM Strong Buy
- PHH
- Analyst Count
- CTNM 4
- PHH 0
- Target Price
- CTNM $29.25
- PHH N/A
- AVG Volume (30 Days)
- CTNM 56.2K
- PHH 41.8K
- Earning Date
- CTNM 03-04-2025
- PHH 01-01-0001
- Dividend Yield
- CTNM N/A
- PHH N/A
- EPS Growth
- CTNM N/A
- PHH N/A
- EPS
- CTNM N/A
- PHH 0.02
- Revenue
- CTNM N/A
- PHH $1,940,443.00
- Revenue This Year
- CTNM N/A
- PHH N/A
- Revenue Next Year
- CTNM N/A
- PHH N/A
- P/E Ratio
- CTNM N/A
- PHH $357.67
- Revenue Growth
- CTNM N/A
- PHH 108.42
- 52 Week Low
- CTNM $7.04
- PHH $3.70
- 52 Week High
- CTNM $22.00
- PHH $6.90
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- PHH N/A
- Support Level
- CTNM N/A
- PHH N/A
- Resistance Level
- CTNM N/A
- PHH N/A
- Average True Range (ATR)
- CTNM 0.00
- PHH 0.00
- MACD
- CTNM 0.00
- PHH 0.00
- Stochastic Oscillator
- CTNM 0.00
- PHH 0.00
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries specialize in providing skincare and cosmetic products under its brand name Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.